NewsRx

Search our medical news database

Arrow International, Inc.

Catheter maker reports on status of CorAide clinical trials

Published in Cardiovascular Business Week, July 5th, 2005

Arrow International, Inc., (ARRO) announced that three additional patients have been implanted with the company's CorAide continuous flow left ventricular assist system (LVAS) as part of its clinical trial of the device in Europe.

In total, five patients have now received CorAide LVAS implants since the clinical trial of the device was resumed in February 2005.

The Diabetes and Heart Center in Bad Oeynhausen, Germany has now implanted four CorAide LVAS devices. Physicians at the Center reported that the device is performing well and allowing patients to recover rapidly from the operative procedure and begin ambulation. The first two CorAide patients...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook